Heart Failure

Latest News

June 7th 2013

Evidence-Based Tack Drives HF Guidelines

April 25th 2013

Aging U.S. to Drive Up Heart-related Health Costs: Study

March 10th 2013

Paul Hauptman, MD, Addresses Patient-Focused Outcomes in Heart Failure

January 16th 2013

NICE Backs New BP Devise to Detect Atrial Fibrillation

July 20th 2012

Hospitals Taking Wide Aim at Readmissions

Success of Telemonitoring Systems Hinges on Features, Design

February 14th 2012

Telemonitoring With Case Management for Seniors With Heart Failure

ByMarcia J. Wade, MD, FCCP, MMM,Akshay S. Desai, MD, MPH,Claire M. Spettell, PhD,Aaron D. Snyder, BA,Virginia McGowan-Stackewicz, RN, CCM,Paula J. Kummer, RN, BA,Maureen C. Maccoy, RN, MBA,Ra

March 17th 2011

An Internet-based telehealth intervention for elderly heart failure patients found no discernible incremental impact on morbidity or mortality compared with case management alone.

Heart Failure

Latest News

Success of Telemonitoring Systems Hinges on Features, Design

Telemonitoring With Case Management for Seniors With Heart Failure

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

OneOncology Partners With OpenEvidence to Give Physicians Access Within Clinical Workflows

High-Dose Vitamin D3 Fails to Improve PFS in Phase 3 Metastatic CRC Trial

After Wild Ride, FDA Grants Accelerated Approval for Replimune’s RP1 Plus Nivolumab in Advanced Melanoma

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Heart Failure

Latest News

Success of Telemonitoring Systems Hinges on Features, Design

Telemonitoring With Case Management for Seniors With Heart Failure

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

OneOncology Partners With OpenEvidence to Give Physicians Access Within Clinical Workflows

High-Dose Vitamin D3 Fails to Improve PFS in Phase 3 Metastatic CRC Trial

After Wild Ride, FDA Grants Accelerated Approval for Replimune’s RP1 Plus Nivolumab in Advanced Melanoma

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups